Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19-Reference-Cited by-同舟云学术

Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19

Published:2020-12-01 Issue:21 Volume:324 Page:2165
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Self Wesley H.¹,Semler Matthew W.²,Leither Lindsay M.³⁴,Casey Jonathan D.²,Angus Derek C.⁵,Brower Roy G.⁶,Chang Steven Y.⁷,Collins Sean P.¹,Eppensteiner John C.⁸,Filbin Michael R.⁹,Files D. Clark¹⁰,Gibbs Kevin W.¹⁰,Ginde Adit A.¹¹,Gong Michelle N.¹²,Harrell Frank E.¹³,Hayden Douglas L.¹⁴,Hough Catherine L.¹⁵,Johnson Nicholas J.¹⁶,Khan Akram¹⁵,Lindsell Christopher J.¹³,Matthay Michael A.¹⁷,Moss Marc¹⁸,Park Pauline K.¹⁹,Rice Todd W.²,Robinson Bryce R. H.²⁰,Schoenfeld David A.¹⁴,Shapiro Nathan I.²¹,Steingrub Jay S.²²,Ulysse Christine A.¹⁴,Weissman Alexandra²³,Yealy Donald M.²³,Thompson B. Taylor²⁴,Brown Samuel M.³⁴,

Affiliation:

1. Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, Tennessee

2. Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee

3. Division of Pulmonary and Critical Care Medicine, Intermountain Medical Center, Murray, Utah

4. University of Utah, Salt Lake City

5. Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania

6. Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland

7. Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Ronald Reagan–UCLA Medical Center, Los Angeles, California

8. Department of Surgery, Duke University, Durham, North Carolina

9. Department of Emergency Medicine, Massachusetts General Hospital, Boston

10. Section of Pulmonary, Critical Care, Allergy and Immunologic Disease, Department of Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina

11. Department of Emergency Medicine, University of Colorado School of Medicine, Aurora

12. Division of Epidemiology and Population Health, Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York

13. Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee

14. Department of Medicine, Massachusetts General Hospital, Boston

15. Division of Pulmonary and Critical Care Medicine, Department of Medicine, Oregon Health and Science University School of Medicine, Portland

16. Department of Emergency Medicine and Division of Pulmonary, Critical Care, and Sleep Medicine, University of Washington, Seattle

17. Cardiovascular Research Institute, Departments of Medicine and Anesthesia, University of California, San Francisco

18. Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado School of Medicine, Aurora

19. Department of Surgery, University of Michigan, Ann Arbor

20. Department of Surgery, University of Washington, Seattle

21. Department of Emergency Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts

22. Department of Medicine, University of Massachusetts Medical School-Baystate, Springfield

23. Department of Emergency Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania

24. Division of Pulmonary and Critical Care Medicine, Department of Medicine, Massachusetts General Hospital, Boston

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2772922/jama_self_2020_oi_200119_1606767652.12648.pdf

Reference37 articles.

1. Cytokine storm and immunomodulatory therapy in COVID-19: role of chloroquine and anti-IL-6 monoclonal antibodies.;Zhao;Int J Antimicrob Agents,2020

2. Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology.;Schrezenmeier;Nat Rev Rheumatol,2020

3. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review.;Sanders;JAMA,2020

4. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.;Wang;Cell Res,2020

5. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).;Yao;Clin Infect Dis,2020

Cited by 342 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Origin Story Part II: Change in Anti-Intellectual Attitude Endorsement;Anti-Scientific Americans;2024-09-16

2. What’s Next, Doc?;Anti-Scientific Americans;2024-09-16

3. The Prevalence of Anti-Intellectual Attitudes;Anti-Scientific Americans;2024-09-16

4. Validating Two Approaches to Measuring Anti-Intellectual Attitude Endorsement in Public-Opinion Surveys;Anti-Scientific Americans;2024-09-16

5. The Nature and Origins of Anti-Intellectualism;Anti-Scientific Americans;2024-09-16